These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11035190)

  • 21. Enhancing DNA vaccine potency against hantavirus by co-administration of interleukin-12 expression vector as a genetic adjuvant.
    Zheng LY; Mou L; Lin S; Lu RM; Luo EJ
    Chin Med J (Engl); 2005 Feb; 118(4):313-9. PubMed ID: 15740670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HSP70 gene fused with Hantavirus S segment DNA significantly enhances the DNA vaccine potency against hantaviral nucleocapsid protein in vivo.
    Li J; Ye ZX; Li KN; Cui JH; Li J; Cao YX; Liu YF; Yang SJ
    Vaccine; 2007 Jan; 25(2):239-52. PubMed ID: 16935395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies.
    Geldmacher A; Skrastina D; Borisova G; Petrovskis I; Krüger DH; Pumpens P; Ulrich R
    Vaccine; 2005 Jun; 23(30):3973-83. PubMed ID: 15917119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and analysis for cross-reactivity among hantaviruses of H-2b-restricted cytotoxic T-lymphocyte epitopes in Sin Nombre virus nucleocapsid protein.
    Maeda K; West K; Toyosaki-Maeda T; Rothman AL; Ennis FA; Terajima M
    J Gen Virol; 2004 Jul; 85(Pt 7):1909-1919. PubMed ID: 15218176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins.
    Meisel H; Wolbert A; Razanskiene A; Marg A; Kazaks A; Sasnauskas K; Pauli G; Ulrich R; Krüger DH
    Clin Vaccine Immunol; 2006 Dec; 13(12):1349-57. PubMed ID: 17021245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.
    Safronetz D; Hegde NR; Ebihara H; Denton M; Kobinger GP; St Jeor S; Feldmann H; Johnson DC
    J Virol; 2009 Jul; 83(14):7285-95. PubMed ID: 19403663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of immune responses against nucleocapsid protein of the Hantaan virus elicited by virus infection or DNA vaccination.
    Woo GJ; Chun EY; Kim KH; Kim W
    J Microbiol; 2005 Dec; 43(6):537-45. PubMed ID: 16410771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of cross-reactive and serotype-specific epitopes on the nucleocapsid proteins of hantaviruses.
    Tischler ND; Rosemblatt M; Valenzuela PD
    Virus Res; 2008 Jul; 135(1):1-9. PubMed ID: 18342973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Puumala hantavirus antibody with ELISA using a recombinant truncated nucleocapsid protein expressed in Escherichia coli.
    Maes P; Keyaerts E; Clement J; Bonnet V; Robert A; Van Ranst M
    Viral Immunol; 2004; 17(2):315-21. PubMed ID: 15279709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge.
    Klingström J; Maljkovic I; Zuber B; Rollman E; Kjerrström A; Lundkvist A
    Vaccine; 2004 Sep; 22(29-30):4029-34. PubMed ID: 15364453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin A responses to Puumala hantavirus.
    de Carvalho Nicacio C; Björling E; Lundkvist A
    J Gen Virol; 2000 Jun; 81(Pt 6):1453-61. PubMed ID: 10811929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced induction of SARS-CoV nucleocapsid protein-specific immune response using DNA vaccination followed by adenovirus boosting in BALB/c mice.
    Chunling M; Kun Y; Jian X; Jian Q; Hua S; Minsheng Z
    Intervirology; 2006; 49(5):307-18. PubMed ID: 16809936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice.
    Bharadwaj M; Lyons CR; Wortman IA; Hjelle B
    Vaccine; 1999 Jul; 17(22):2836-43. PubMed ID: 10438054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of monoclonal antibodies against hantavirus nucleocapsid protein and their use for immunohistochemistry on rodent and human samples.
    Kucinskaite-Kodze I; Petraityte-Burneikiene R; Zvirbliene A; Hjelle B; Medina RA; Gedvilaite A; Razanskiene A; Schmidt-Chanasit J; Mertens M; Padula P; Sasnauskas K; Ulrich RG
    Arch Virol; 2011 Mar; 156(3):443-56. PubMed ID: 21161552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and evaluation of DNA vaccine encoding Hantavirus glycoprotein N-terminal fused with lysosome-associated membrane protein.
    Jiang DB; Sun YJ; Cheng LF; Zhang GF; Dong C; Jin BQ; Song CJ; Ma Y; Zhang FL; Yang K
    Vaccine; 2015 Jun; 33(29):3367-76. PubMed ID: 26027907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological assays for the detection of human andes hantavirus infections based on its yeast-expressed nucleocapsid protein.
    Schmidt J; Meisel H; Capria SG; Petraityte R; Lundkvist A; Hjelle B; Vial PA; Padula P; Krüger DH; Ulrich R
    Intervirology; 2006; 49(3):173-84. PubMed ID: 16428893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant DNA vaccine of Hantavirus Gn and LAMP1 induced long-term immune protection in mice.
    Jiang DB; Sun LJ; Cheng LF; Zhang JP; Xiao SB; Sun YJ; Yang SY; Wang J; Zhang FL; Yang K
    Antiviral Res; 2017 Feb; 138():32-39. PubMed ID: 27923570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnostics.
    Salonen EM; Parren PW; Graus YF; Lundkvist A; Fisicaro P; Vapalahti O; Kallio-Kokko H; Vaheri A; Burton DR
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():659-65. PubMed ID: 9568958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.
    Brocato RL; Josleyn MJ; Wahl-Jensen V; Schmaljohn CS; Hooper JW
    Clin Vaccine Immunol; 2013 Feb; 20(2):218-26. PubMed ID: 23239797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Tula virus antigenic determinants defined by monoclonal antibodies raised against baculovirus-expressed nucleocapsid protein.
    Lundkvist A; Vapalahti O; Plyusnin A; Sjölander KB; Niklasson B; Vaheri A
    Virus Res; 1996 Nov; 45(1):29-44. PubMed ID: 8896239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.